OA12635A - Formulation pharmaceutique au goût masqué et son procédé de préparation. - Google Patents

Formulation pharmaceutique au goût masqué et son procédé de préparation. Download PDF

Info

Publication number
OA12635A
OA12635A OA1200300340A OA1200300340A OA12635A OA 12635 A OA12635 A OA 12635A OA 1200300340 A OA1200300340 A OA 1200300340A OA 1200300340 A OA1200300340 A OA 1200300340A OA 12635 A OA12635 A OA 12635A
Authority
OA
OAPI
Prior art keywords
active ingredient
polymer
formulation
formulation according
matrix
Prior art date
Application number
OA1200300340A
Other languages
English (en)
French (fr)
Inventor
Philippe Becourt
Josiane Chauvin
Detlev Schabe
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of OA12635A publication Critical patent/OA12635A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA1200300340A 2001-06-21 2002-06-21 Formulation pharmaceutique au goût masqué et son procédé de préparation. OA12635A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (1)

Publication Number Publication Date
OA12635A true OA12635A (fr) 2006-06-15

Family

ID=8864587

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300340A OA12635A (fr) 2001-06-21 2002-06-21 Formulation pharmaceutique au goût masqué et son procédé de préparation.

Country Status (42)

Country Link
US (2) US7138138B2 (es)
EP (1) EP1401397B1 (es)
JP (1) JP4880871B2 (es)
CN (1) CN1239149C (es)
AP (1) AP1595A (es)
AR (1) AR036096A1 (es)
AT (1) ATE290366T1 (es)
AU (1) AU2002329311B2 (es)
BG (1) BG66314B1 (es)
BR (1) BRPI0208998A2 (es)
CA (1) CA2452239C (es)
CO (1) CO5540278A2 (es)
CZ (1) CZ299947B6 (es)
DE (1) DE60203178T2 (es)
EA (1) EA006016B1 (es)
EC (1) ECSP034915A (es)
ES (1) ES2236574T3 (es)
FR (1) FR2826274B1 (es)
GT (2) GT200200115A (es)
HK (1) HK1067558A1 (es)
HR (1) HRP20031067B1 (es)
HU (1) HUP0400799A3 (es)
IL (2) IL159404A0 (es)
JO (1) JO2325B1 (es)
MA (1) MA27042A1 (es)
MX (1) MXPA03011756A (es)
MY (1) MY134340A (es)
NO (1) NO332258B1 (es)
NZ (1) NZ530042A (es)
OA (1) OA12635A (es)
PA (1) PA8548301A1 (es)
PE (1) PE20030201A1 (es)
PL (1) PL202090B1 (es)
PT (1) PT1401397E (es)
SK (1) SK285865B6 (es)
SV (1) SV2003001098A (es)
TN (1) TNSN03141A1 (es)
TW (1) TWI228049B (es)
UA (1) UA77960C2 (es)
UY (1) UY27341A1 (es)
WO (1) WO2003000225A2 (es)
ZA (1) ZA200309479B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) * 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) * 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
PL1978936T3 (pl) * 2006-02-03 2013-11-29 Evonik Roehm Gmbh Kompozycje farmaceutyczne zawierające mieszaniny polimerów i trudno rozpuszczalnych w wodzie substancji czynnych
US20100226979A1 (en) * 2006-03-21 2010-09-09 Jubilant Organosys Limited Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
WO2009055557A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
MY158710A (en) 2008-12-16 2016-11-15 Carlsberg As Coating of hydroxylated surfaces by gas phase grafting
RU2658050C2 (ru) 2012-03-27 2018-06-19 Семпра Фармасьютикалз, Инк. Парентеральные составы для введения макролидных антибиотиков
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
CN106604729A (zh) * 2014-08-05 2017-04-26 森普拉制药公司 抗菌剂的粉末口服混悬制剂
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
CA2304630A1 (en) * 1997-10-03 1999-04-15 Elan Corporation, Plc Taste masked formulations
IN191239B (es) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
WO2002016380A1 (en) * 2000-08-22 2002-02-28 Basilea Pharmaceutica Ag New macrolides with antibacterial activity

Also Published As

Publication number Publication date
EP1401397A2 (fr) 2004-03-31
WO2003000225A2 (fr) 2003-01-03
HUP0400799A3 (en) 2012-08-28
JP2004534810A (ja) 2004-11-18
EA006016B1 (ru) 2005-08-25
WO2003000225A3 (fr) 2003-03-13
BG108458A (bg) 2005-02-28
CZ299947B6 (cs) 2009-01-07
MY134340A (en) 2007-12-31
CA2452239C (fr) 2011-07-19
IL159404A0 (en) 2004-06-01
JP4880871B2 (ja) 2012-02-22
PA8548301A1 (es) 2003-09-05
NO20035581D0 (no) 2003-12-15
EP1401397B1 (fr) 2005-03-09
DE60203178D1 (de) 2005-04-14
CZ20033441A3 (en) 2004-03-17
UA77960C2 (en) 2007-02-15
MA27042A1 (fr) 2004-12-20
GT200200115AA (es) 2005-01-12
SK15922003A3 (sk) 2004-05-04
PL202090B1 (pl) 2009-06-30
ZA200309479B (en) 2005-04-26
ES2236574T3 (es) 2005-07-16
CO5540278A2 (es) 2005-07-29
CN1239149C (zh) 2006-02-01
SV2003001098A (es) 2003-03-18
HK1067558A1 (en) 2005-04-15
AP1595A (en) 2006-04-12
HRP20031067A2 (en) 2004-04-30
FR2826274B1 (fr) 2003-09-26
HUP0400799A2 (hu) 2004-08-30
UY27341A1 (es) 2003-01-31
DE60203178T2 (de) 2006-01-26
PT1401397E (pt) 2005-05-31
PE20030201A1 (es) 2003-03-12
GT200200115A (es) 2003-02-27
US7138138B2 (en) 2006-11-21
JO2325B1 (en) 2006-06-28
BRPI0208998A2 (pt) 2017-06-06
US20040142029A1 (en) 2004-07-22
MXPA03011756A (es) 2004-07-01
TNSN03141A1 (fr) 2005-12-23
CA2452239A1 (fr) 2003-01-03
BG66314B1 (bg) 2013-04-30
PL366803A1 (en) 2005-02-07
HRP20031067B1 (en) 2011-10-31
CN1529585A (zh) 2004-09-15
AR036096A1 (es) 2004-08-11
US20070014857A1 (en) 2007-01-18
NO332258B1 (no) 2012-08-13
TWI228049B (en) 2005-02-21
FR2826274A1 (fr) 2002-12-27
ATE290366T1 (de) 2005-03-15
EA200400061A1 (ru) 2004-06-24
AU2002329311B2 (en) 2007-02-01
IL159404A (en) 2007-08-19
SK285865B6 (sk) 2007-10-04
ECSP034915A (es) 2004-02-26
AP2003002927A0 (en) 2003-12-31
NZ530042A (en) 2005-09-30

Similar Documents

Publication Publication Date Title
CA2799407C (fr) Forme pharmaceutique orale alcoolo-resistante
CA2452239C (fr) Formulation pharmaceutique au gout masque et son procede de preparation
EP2349227B1 (fr) Forme pharmaceutique orale a base de microgranules a liberation prolongee resistante a l'alcool
EP2672961B1 (fr) Granules effervescents d'acide gamma-hydroxybutyrique
CA2771053C (fr) Microgranules flottants
FR2960776A1 (fr) Microgranules et microcomprimes resistants au detournement
EP1126829B1 (fr) Particules enrobees d'ibuprofene cristallin granule
WO2000069414A2 (fr) Granules contenant une substance vegetale et leur procede de preparation
FR2790668A1 (fr) Granules contenant une substance vegetale et leur procede de preparation
WO2002072072A2 (fr) Granules et granules enrobes au gout masque
FR2708852A1 (fr) Composition à base d'acide acétylsalicylique à biodisponibilité améliorée et procédé pour la produire.
WO2022263502A1 (en) Methods of granulation and encapsulation of an active ingredient
FR2791889A1 (fr) Suspension pharmaceutique buvable d'ibuprofene
MXPA00002099A (es) Una composicion farmaceutica que tiene dos capas de recubrimiento